Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Onconetix (ONCO)

Annual Return

Over the past 3 years, ONCO has had an average annual return of -95.82%, underperforming the benchmark SPY, which returned +19.31% annual.

Since Feb 18, 2022, ONCO has had an average annual return of -94.90%, underperforming the benchmark SPY, which returned +14.46% annual.

2025202420232022
-66.67%-91.18%-82.29%-98.08%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2025-33.33%-50.00%+0%-66.67%
2024-2.94%-9.09%-10.00%-25.93%+80%-19.44%-6.90%-11.11%-4.17%-43.48%-76.92%+0%-91.18%
2023+11.46%-4.67%-8.82%-0%-24.73%+40.71%-0%-29.44%-35.97%-23.60%-38.24%-19.05%-82.29%
2022-13.59%+13.91%-93.65%+22.88%-51.69%+57.41%-5.99%-45.72%-27.52%+2.31%-13.12%-98.08%

Drawdown analysis of Onconetix (ONCO)

The maximum drawdown for the ONCO was -99.99%, occurring on Dec 24, 2024. This drawdown has not yet recovered.

The current ONCO drawdown is -99.99%.

Since Feb 18, 2022 ONCO has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 2 times
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Mar 15, 2022699Dec 24, 2024OngoingOngoingOngoing
-25.43%Feb 18, 20223Feb 24, 20224Mar 2, 20227
-4.85%Mar 10, 20222Mar 14, 20221Mar 15, 20223
-3.35%Mar 3, 20223Mar 8, 20222Mar 10, 20225